Inovalon Announces Third Quarter 2019 Earnings Conference Call
BOWIE, Md., Oct. 16, 2019 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, […]
Luminex Announces Granting of Options
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) — Luminex Resources Corp. (TSXV: LR) (US OTC: LUMIF) (the “Company” or […]
Fireweed Drills 250 m True Width of 3.44% Zinc from Surface at Boundary Including Intersections of 23.31m of 16.35% Zinc and 11.85m of 13.63% Zinc+Lead
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed”) (TSXV: FWZ) is pleased to announce results […]
FTI Consulting Continues Financial Services Practice Growth with Appointment of Two Professionals
WASHINGTON, Oct. 16, 2019 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Naidira Alemova as […]
Kforce Inc. Announces Participation in the J.P. Morgan Ultimate Services Conference
TAMPA, Fla., Oct. 16, 2019 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC), a provider of professional staffing services and solutions, […]
Sol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology Conference
NESS ZIONA, Israel, Oct. 16, 2019 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) today announced it will present research […]
Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD
Phase 2a studies of ABI-H0731 + nucleos(t)ide analogs (Nrtl) in HBeAg+ patients show faster and deeper declines in HBV DNA […]
WeedMD Secures Health Canada Licence for 50,000-Square-Foot Purpose-Built Cannabis Processing Facility
TORONTO, Oct. 16, 2019 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]
Orgenesis Announces Co-Development Agreement with Accellix
GERMANTOWN, Md., Oct. 16, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a leading cell and […]
Axsome Therapeutics Announces Completion of Patient Enrollment in the GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder
NEW YORK, Oct. 16, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
